Conmed Buys ExoShape® ACL Product Line

Disposal allows MedShape to concentrate on core foot and ankle franchise

Conmed is to acquire MedShape’s PEEK, interference fit ExoShape® ACL fixation system.

Background

Conmed Corporation and MedShape, Inc., have reached a definitive agreement that sees Conmed acquiring both the ExoShape Femoral and Tibial Soft Tissue Fasteners, used to fixate soft tissue grafts in anterior cruciate ligament (ACL) reconstruction surgery.

MedShape tells us its ExoShape ACL Fixation System was the first all-PEEK implant to offer a non-rotational deployment and interference fixation approach for ACL reconstruction. Manufactured out of shape memory PEEK Altera, the ExoShape fasteners are delivered in a low-profile shape for easy insertion and then fully expanded upon instantaneous deployment to effectively compress and secure the soft tissue graft inside the bone tunnel.

Company comments

“The ExoShape System has represented a valuable portion of MedShape’s business since 2011, and this acquisition further demonstrates the success of the development and commercialization efforts invested in the product,” said Kurt Jacobus, MedShape’s CEO. “While we will certainly miss serving our patients, doctors and distributors with this product line, we look forward to focusing our efforts towards growing our core foot and ankle business with new investments.”

 

Source: MedShape, Inc.

published: July 6, 2017 in: Knee, Mergers and Acquisitions, Sports

Leave a Reply

Your email address will not be published. Required fields are marked *

Most read

Latest

^